Silver Gabrielle Alison Insider Trades

Insider Trading History

Track insider trading activity for Silver Gabrielle Alison. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Director
Holding Value $41.3k 2,000 shares
Last Trade
Mar 02, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$506k 25,843 shares
$19.57
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Director
Holding Value $482k 23,343 shares
Last Trade
Jun 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.3k 2,000 shares
$10.64
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Director
Holding Value $441k 21,343 shares
Last Trade
May 16, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$33.2k 2,500 shares
$13.29
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Director
Holding Value $389k 18,843 shares
Last Trade
Jun 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.9k 4,500 shares
$13.30
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Director
Holding Value $0 0 shares
Last Trade
May 13, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.53k 365 shares
$12.40
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Director
Holding Value $348k 16,843 shares
Last Trade
May 13, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.53k 365 shares
$12.40
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Director
Holding Value $7.54k 365 shares
Last Trade
Mar 17, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$78.9k 7,886 shares
$10.00
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Director
Holding Value $340k 16,478 shares
Last Trade
Mar 17, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$79.2k 7,157 shares
$11.07
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Director
Holding Value $488k 23,635 shares
Last Trade
Mar 17, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$78.9k 7,886 shares
$10.00
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Director
Holding Value $365k 17,698 shares
Last Trade
Mar 16, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$25.5k 2,231 shares
$11.41
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Director
Holding Value $325k 15,749 shares
Last Trade
Mar 16, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$22.4k 1,949 shares
$11.50
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Director
Holding Value $170k 8,251 shares
Last Trade
Mar 16, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$25.5k 2,231 shares
$11.41
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Director
Holding Value $400k 19,367 shares
Last Trade
Mar 15, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$52.3k 4,518 shares
$11.57
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Director
Holding Value $319k 15,467 shares
Last Trade
Mar 15, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$45.4k 3,900 shares
$11.64
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Director
Holding Value $216k 10,482 shares
Last Trade
Mar 15, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$52.3k 4,518 shares
$11.57
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Director
Holding Value $310k 15,000 shares
Last Trade
Mar 05, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$103k 8,334 shares
$12.41
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Director
Holding Value $307k 14,849 shares
Last Trade
Mar 05, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$103k 8,334 shares
$12.41
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Director
Holding Value $135k 6,515 shares
Last Trade
Jun 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.6k 4,500 shares
$8.79
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Director
Holding Value $93.2k 4,515 shares
Last Trade
Jun 10, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$24.9k 2,730 shares
$9.13
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Director
Holding Value $36.9k 1,785 shares
Last Trade
Nov 22, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$24.1k 1,785 shares
$13.51
$20.65

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up